Form D · Biotechnology
Mazen Animal Health Inc.
Ames, IA · CIK 0001843717
Offering snapshot reported May 26, 2022 · SEC filing
- Reported sold
- $11.3M Offering amount: $12M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 29, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 26, 2022 | Initial | $11,273,320 | No comparison | 14 | SEC filing |
| Feb 2, 2021 | Initial | $2,195,038 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-447049
Offer and sale of shares of preferred stock and the underlying shares of common stock issuable upon conversion thereof.
Source: Form D, filed May 26, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Terry Coffey | Director |
| Kevin Fields | Director |
| Jennifer Ann Filbey | Director, Executive |
| Joel Harris | Director |
| John Howard | Director |
| Eric O'brien | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1805 Collaboration Place Suite 1250
Ames, IA, 50010
Ames, IA, 50010